Skip to main content
Fig. 2 | BMC Cardiovascular Disorders

Fig. 2

From: Serum cystatin C is associated with the prognosis in acute myocardial infarction patients after coronary revascularization: a systematic review and meta-analysis

Fig. 2

The forest plot of serum cystatin C contributes for the prognosis of AMI patients after coronary revascularization. a The association between serum cystatin C and MACE risk in AMI patients after coronary revascularization. b The association between serum cystatin C and mortality risk of AMI patients after coronary revascularization. The risk ratio (RR) is used to evaluate the MACE or mortality risk

Back to article page